Acoustic Startle Reduction In Cocaine Dependence
NCT00430690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144
Last updated 2019-08-07
Summary
Chronic cocaine administration leads to changes in brain function that persist long after the acute withdrawal phase. The acoustic startle response (ASR) is a well characterized reflexive response to a sudden acoustic stimulus. The ASR is mediated by a simple 3-synapse subcortical circuit; it is modulated in part by brain areas and neurotransmitters associated with cocaine administration. Our initial study and subsequent replication reveals a profound diminution of the ASR in cocaine-dependent subjects after a brief period of abstinence. Our preliminary findings indicate that first degree relatives of cocaine-dependent subjects also have reduced startle compared to healthy controls. The findings of low ASR in rats and humans during cocaine washout and low ASR in family members suggests there may be both a trait and state component of the startle reductions we have reported.
The central objectives of this proposal are to dissect this finding with regard to its development and persistence in early and later phases of cocaine abstinence in humans; to ascertain whether startle reduction and its potential normalization during later abstinence is a predictor of clinical course in human subjects with cocaine dependence; and to examine whether startle reduction is, at least in part, a vulnerability trait for the development of cocaine dependence. This latter Aim will be carried out in humans by testing siblings of cocaine-dependent subjects.
Cocaine dependence is an enormous public health problem. The significance of this work lies in the potential for the ASR reduction to serve as a reliable, easily repeatable biological measure of cocaine-induced brain changes that may enhance outcome prediction so that tailored treatments may be directed at those patients most vulnerable to relapse, given the restriction of resources for available for substance abuse treatment.
Conditions
- Cocaine-Related Disorders
Interventions
- PROCEDURE
-
acoustic startle testing
acoustic startle testing: listening to sounds through headphones while the eyeblink component of the acoustic startle reflex is recorded with small surface electrodes
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Emory University
lead OTHER
Principal Investigators
-
Erica Duncan, MD · Emory University / Atlanta VA
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2011-07-19
- Completion
- 2011-07-19
Countries
- United States
Study Locations
More Related Trials
-
Impulsivity, Neural Deficits and Cocaine Addiction
NCT00744601 ·Status: COMPLETED
-
Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer
NCT02383043 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Acute Withdrawal From Smoked Cocaine - 9
NCT00000292 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Glutamatergic Modulation on Cocaine Self-administration
NCT02596022 ·Status: COMPLETED ·Phase: PHASE2
-
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
NCT03344419 ·Status: SUSPENDED ·Phase: PHASE3
-
Brain Function and Structure in Cocaine Dependence
NCT02080832 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.
NCT02255357 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
NCT06125054 ·Status: RECRUITING ·Phase: PHASE2
-
Dopamine Rhythms in Health and Addiction
NCT02233829 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Infusion Laboratory: Protocol 3 (Risperidone) - 4
NCT00000339 ·Status: UNKNOWN ·Phase: PHASE1
-
Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates
NCT00865332 ·Status: WITHDRAWN
-
Cocaine Use Reduction and Health
NCT03224546 ·Status: COMPLETED ·Phase: NA
-
Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
NCT00000309 ·Status: TERMINATED ·Phase: PHASE2
-
Glutamatergic Modulation of Cocaine-related Deficits
NCT01790490 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence
NCT01468012 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Metabolic Effects of Cocaine
NCT00451230 ·Status: COMPLETED ·Phase: NA
-
Neural Substrates of Emotion: Impact of Cocaine Dependence
NCT02682784 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Clonidine on Responses to Imagery Scripts
NCT00318760 ·Status: COMPLETED ·Phase: PHASE1
-
Agonist Replacement Therapy for Cocaine Dependence
NCT00697138 ·Status: COMPLETED ·Phase: PHASE1
-
Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving
NCT01929343 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
NCT00134901 ·Status: COMPLETED ·Phase: PHASE2
-
New Medication Treatment for Stimulant Dependence
NCT00689572 ·Status: COMPLETED ·Phase: PHASE2
-
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208 ·Status: COMPLETED ·Phase: NA
-
Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
NCT00895557 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
NCT00385268 ·Status: COMPLETED ·Phase: PHASE2